These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 26187744)

  • 1. Detection of a TRAF1-ALK fusion in an anaplastic large cell lymphoma patient with chemotherapy and ALK inhibitor-resistant disease.
    Lawrence K; Berry B; Handshoe J; Hout D; Mazzola R; Morris SW; Saltman DL
    BMC Res Notes; 2015 Jul; 8():308. PubMed ID: 26187744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Screening in Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma: Anaplastic Lymphoma Kinase Analysis, Next-Generation Sequencing Fusion Gene Detection, and T-Cell Receptor Immunoprofiling.
    Kalinova M; Mrhalova M; Kabickova E; Svaton M; Skotnicova A; Prouzova Z; Krenova Z; Kolenova A; Divoka M; Fronkova E; Kodet R
    Mod Pathol; 2024 Mar; 37(3):100428. PubMed ID: 38266918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic efficacy of the bromodomain inhibitor OTX015/MK-8628 in ALK-positive anaplastic large cell lymphoma: an alternative modality to overcome resistant phenotypes.
    Boi M; Todaro M; Vurchio V; Yang SN; Moon J; Kwee I; Rinaldi A; Pan H; Crescenzo R; Cheng M; Cerchietti L; Elemento O; Riveiro ME; Cvitkovic E; Bertoni F; Inghirami G;
    Oncotarget; 2016 Nov; 7(48):79637-79653. PubMed ID: 27793034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of TRAF1-ALK fusion in skin lesions of systemic ALK+ anaplastic large cell lymphoma initially involving the skin and the draining lymph node.
    Norimatsu Y; Akatsuka T; Matsuoka A; Hamada T; Mori I; Shiomi T; Mori N; Onishi K; Togashi Y; Inoue N; Takeuchi K; Sugaya M
    J Dermatol; 2024 Jan; 51(1):120-124. PubMed ID: 37753577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anaplastic large cell lymphoma: pathology, genetics, and clinical aspects.
    Tsuyama N; Sakamoto K; Sakata S; Dobashi A; Takeuchi K
    J Clin Exp Hematop; 2017; 57(3):120-142. PubMed ID: 29279550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variant ALK-fusion positive anaplastic large cell lymphoma (ALCL): A population-based paediatric study of the NHL-BFM study group.
    Luedersen J; Stadt UZ; Richter J; Oschlies I; Klapper W; Rosenwald A; Kalinova M; Simonitsch-Klupp I; Siebert R; Zimmermann M; Qi M; Nakel J; Scheinemann K; Knörr F; Attarbaschi A; Kabickova E; Woessmann W; Damm-Welk C
    Br J Haematol; 2024 May; 204(5):1894-1898. PubMed ID: 38279625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determining the contribution of NPM1 heterozygosity to NPM-ALK-induced lymphomagenesis.
    Mduff FK; Hook CE; Tooze RM; Huntly BJ; Pandolfi PP; Turner SD
    Lab Invest; 2011 Sep; 91(9):1298-303. PubMed ID: 21709672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case report: Differential diagnosis of highly amplified anti-CD5 CAR T cells and relapsed lymphoma cells in a patient with refractory ALK positive anaplastic large cell lymphoma.
    Mu W; Zhang M; Hu G; Han Y; Mao X; Chen C; Shen K; Dai Z; Zhu X; Zhou X; Huang L; Ao Q; Xiao M
    Front Immunol; 2023; 14():1280007. PubMed ID: 38143760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALK-negative anaplastic large cell lymphoma with JAK2 rearrangement mimicking classic Hodgkin lymphoma.
    Jaye DL; Feldman AL
    Blood; 2023 Apr; 141(17):2160. PubMed ID: 37103947
    [No Abstract]   [Full Text] [Related]  

  • 10. Chimeric kinase ALK induces expression of NAMPT and selectively depends on this metabolic enzyme to sustain its own oncogenic function.
    Zhang Q; Basappa J; Wang HY; Nunez-Cruz S; Lobello C; Wang S; Liu X; Chekol S; Guo L; Ziober A; Nejati R; Shestov A; Feldman M; Glickson JD; Turner SD; Blair IA; Van Dang C; Wasik MA
    Leukemia; 2023 Dec; 37(12):2436-2447. PubMed ID: 37773266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ALK-rearranged CD30-positive poorly differentiated lung adenocarcinoma, mimicking anaplastic large-cell lymphoma.
    George GV; Wallace DS; Wang Y; Carney J; Elsadawi M; Burack WR; Evans AG; Barr PM; Velez MJ; El Hussein S
    Histopathology; 2024 Apr; 84(5):900-902. PubMed ID: 38032068
    [No Abstract]   [Full Text] [Related]  

  • 12. Alectinib, an anaplastic lymphoma kinase (ALK) inhibitor, as a bridge to allogeneic stem cell transplantation in a patient with ALK-positive anaplastic large-cell lymphoma refractory to chemotherapy and brentuximab vedotin.
    Nakai R; Fukuhara S; Maeshima AM; Kim SW; Ito Y; Hatta S; Suzuki T; Yuda S; Makita S; Munakata W; Suzuki T; Maruyama D; Izutsu K
    Clin Case Rep; 2019 Dec; 7(12):2500-2504. PubMed ID: 31893088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anaplastic Large-cell Lymphoma in Children: State of the Art in 2023.
    Khoubila N; Sraidi S; Madani A; Tazi I
    J Pediatr Hematol Oncol; 2024 Jul; 46(5):217-224. PubMed ID: 38912833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anaplastic large cell lymphoma with ALK::ATIC fusion mimicking a histiocytic sarcoma debuting as an anterior thoracic soft tissue tumor with exceptional clinicopathological, morphological and molecular features.
    García-Muñiz JA; Vilches-Cisneros N; Flores-Gutiérrez JP; Barboza-Quintana O
    Thorac Cancer; 2024 May; 15(13):1103-1105. PubMed ID: 38523398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of minimal disseminated disease assessed using digital polymerase chain reaction for 3'
    Fukano R; Iijima-Yamashita Y; Iwafuchi H; Nakazawa A; Saito AM; Takimoto T; Sekimizu M; Suehiro Y; Yamasaki T; Hasegawa S; Mori T; Horibe K
    Haematologica; 2024 Feb; 109(2):652-656. PubMed ID: 37675509
    [No Abstract]   [Full Text] [Related]  

  • 16.
    Xiao A; Shahmarvand N; Nagy A; Kumar J; Van Ziffle J; Devine P; Huang F; Lezama L; Li P; Ohgami RS
    Front Oncol; 2023; 13():1174606. PubMed ID: 37305584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Papillary thyroid carcinoma coexisting with ALK-negative anaplastic large-cell lymphoma: An exceptional clinical case report.
    Guo Z; Ali H; Wang S; Li J
    Asian J Surg; 2024 Mar; 47(3):1589-1591. PubMed ID: 38087686
    [No Abstract]   [Full Text] [Related]  

  • 18. The germacranolide sesquiterpene lactone neurolenin B of the medicinal plant Neurolaena lobata (L.) R.Br. ex Cass inhibits NPM/ALK-driven cell expansion and NF-κB-driven tumour intravasation.
    Unger C; Kiss I; Vasas A; Lajter I; Kramer N; Atanasov AG; Nguyen CH; Chatuphonprasert W; Brenner S; Krieger S; McKinnon R; Peschel A; Kain R; Saiko P; Szekeres T; Kenner L; Hassler MR; Diaz R; Frisch R; Dirsch VM; Jäger W; de Martin R; Bochkov VN; Passreiter CM; Peter-Vörösmarty B; Mader RM; Grusch M; Dolznig H; Kopp B; Zupko I; Hohmann J; Krupitza G
    Phytomedicine; 2015 Aug; 22(9):862-74. PubMed ID: 26220634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethanol activates midkine and anaplastic lymphoma kinase signaling in neuroblastoma cells and in the brain.
    He D; Chen H; Muramatsu H; Lasek AW
    J Neurochem; 2015 Nov; 135(3):508-21. PubMed ID: 26206265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Capability of Next-Generation Sequencing Fusion Analysis in Identifying a Rare CASE of
    Agarwal I; Sabatini L; Alikhan MB
    Front Oncol; 2020; 10():730. PubMed ID: 32457846
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.